Palvella Therapeutics, Inc. Operating Leases, Future Minimum Payments, Due in Four Years
Palvella Therapeutics, Inc. (PVLA) had Operating Leases, Future Minimum Payments, Due in Four Years of $2.35 million as of 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2019-03-18
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $2.35M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $204.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $199.86K.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $195.91K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-12-31 | $2.35M 10-K · filed 2019-03-18 |
| 2017-12-31 | $204.00K 10-K · filed 2018-03-15 |
| 2016-12-31 | $199.86K 10-K · filed 2017-03-30 |
| 2015-12-31 | $195.91K 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |